Dear researchers,

Please find attached a draft of the 2020 programme for Innovative Medicines Initiative.

The main topics are these and they are presented in more detail in the attached pdf.

The programme is open for commenting so if you are interested in the topics and wish to make an input to the programme, please just send me your comments (no later than 28.10) and I will forward them collectively and anonymously.

IMI-calls are partly funded by the EU and partly by health tech/med tech/pharma companies and are open to consortia with a minimum of 3 organizations from 3 different EU-countries.

With best regards,

Emma

IMI2 Call 20 topics are:

- Topic 1: Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in Psoriatic Arthritis

- Topic 2: Innovations to accelerate vaccine development and manufacture

- Topic 3: Real-world clinical implementation of liquid biopsy

- Topic 4: Tumour plasticity

- Topic 5: Proton versus photon therapy for oesophageal cancer – a trimodality strategy

- Topic 6: Handling of protein drug products and stability concerns

- Topic 7: Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)